A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia.
Zaudig M; Drug Safety, 2000, vol. 23, issue 3, p 183, ISSN 01145916. ISBN 01145916.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef